Icecure Medical is trading at $1.19, with a +8.18% move in after-hours trading; no clear catalyst was identified.
- Its latest company release was October 6, announcing a new clinical site for its ChoICE study. No October 9 company announcement explaining the after-hours rise appeared in the press-release listing.
- The gain followed seven consecutive declining closes. Major U.S. indexes rose during October 9’s session, but that broader strength does not establish a cause for this after-hours move.